13. Stockholders' Equity |
13. Stockholders’ Equity Common Stock For the period ended August 31, 2022 | | Number of shares | | | Amount | | Balance, February 28, 2022 | | | 47,388,056 | | | $ | 4,740 | | Issuance of shares upon settlement of restricted stock units | | | 12,653 | | | | 1 | | Balance, August 31, 2022 | | | 47,400,709 | | | $ | 4,741 | |
For the period ended August 31, 2021 | | Number of shares | | | Amount | | Balance, February 28, 2021 | | | 42,413,691 | | | $ | 4,242 | | Issuance of shares upon settlement of restricted stock units | | | 31,660 | | | | 4 | | Issuance of shares for cash | | | 4,714,813 | | | | 471 | | Balance, August 31, 2021 | | | 47,160,164 | | | $ | 4,717 | |
During the six-month period ended August 31, 2022, the Company recorded the following common stock transaction: (i) | The Company issued 12,653 shares of the common stock to settle restricted stock units that vested in the period. |
During the six-month period ended August 31, 2021, the Company recorded the following common stock transactions: (i) | The Company issued 31,660 shares of the common stock to settle restricted stock units that vested in the period. | (ii) | The Company issued 4,714,813 shares of its common stock, with warrants, at an aggregate offering price of $12.00 per share for total gross proceeds of $56,577,756 and net proceeds of $56,084,304. |
|